GMP Human TGF-Beta 1 / TGFB1 Protein
優(yōu)勢特色(Features)
1. Designed under ISO 9001:2015 and ISO 13485:2016
2. Manufactured and QC tested under a GMP compliance factory
3. Animal-Free materials
4. Beta-lactam materials free
5. Batch-to-batch consistency
6. Stringent quality control tests
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
GMP Human TGF-Beta 1 Protein (GMP-TG1H25) is expressed from human 293 cells (HEK293). It contains AA Ala 279 - Ser 390 (Accession # P01137-1).
Predicted N-terminus: Ala 279
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries no "tag".
The protein has a calculated MW of 12.8 kDa. The protein migrates as 13 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
內(nèi)毒素(Endotoxin)
Less than 10 EU/mg by the LAL method.
宿主蛋白殘留(Host Cell Protein)
<0.5 ng/μg of protein tested by ELISA.
宿主核酸殘留(Host Cell DNA)
<0.02 ng/μg of protein tested by qPCR.
無菌(Sterility)
The sterility testing was performed by membrane filtration method described in CP<1101>, USP<71> and Eur. Ph. 2.6.1.
支原體(Mycoplasma)
Negative.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 100 mM HAC, pH3.0 with protectants.
Contact us for customized product form or formulation.
運輸(Shipping)
This product is supplied and shipped with blue ice, please inquire the shipping cost.
存儲(Storage)
Upon receipt, store it immediately at -20°C or lower for long term storage.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 5 years in lyophilized state;
-70°C for 12 months under sterile conditions after reconstitution.
ACRO GMP產(chǎn)品制造規(guī)范
ACROBiosystems GMP級產(chǎn)品是在質(zhì)量管理體系下生產(chǎn)的,并符合相關(guān)指南:
Ph. Eur General Chapter 5.2.12 Raw materials of biological origin for the production of cell-based and gene therapy medicinal products; USP <92> Growth Factors and Cytokines Used in Cell Therapy Manufacturing; USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products; ISO/TS 20399-1:2018, Biotechnology - Ancillary Materials Present During the Production of Cellular Therapeutic Products.
ACROBiosystems質(zhì)量管理體系內(nèi)容:
1. 根據(jù)ISO 9001:2015和ISO 13485:2016進(jìn)行設(shè)計,在GMP工廠進(jìn)行制造和QC檢測
2. 無動物成分
3. QA從批準(zhǔn)的供應(yīng)商處采購的材料
4. ISO 5潔凈室和自動灌裝設(shè)備
5. 人員合格
6. 質(zhì)量保證審核和批準(zhǔn)質(zhì)量相關(guān)文件
7. 全批量生產(chǎn)和控制記錄
8. 設(shè)備維護(hù)和校準(zhǔn)
9. 分析程序的驗證
10. 進(jìn)行的穩(wěn)定性研究
11. 全面的法規(guī)支持文件
ACROBiosystems對我們的GMP級產(chǎn)品提供嚴(yán)格的質(zhì)量控制測試(經(jīng)過充分驗證的設(shè)備、工藝和測試方法),以確保它們在純度、安全性、活性和批間穩(wěn)定性方面符合嚴(yán)格的標(biāo)準(zhǔn),每個批量QC批次主要包含以下具體信息:
1. SDS-PAGE
2. 蛋白質(zhì)含量
3. 內(nèi)毒素水平
4. 殘留宿主細(xì)胞DNA含量
5. 殘留宿主細(xì)胞蛋白質(zhì)含量
6. 生物活性分析
7. 微生物檢測
8. 支原體檢測
9. 體外病毒測定
10. 殘留水分
11. 批次間一致性
ACRO產(chǎn)品聲明
ACROBiosystems GMP級產(chǎn)品專為研究、生產(chǎn)或離體使用而設(shè)計。注意:不可直接供人體使用。
背景(Background)
轉(zhuǎn)化生長因子β1(TGFB1)也稱為TGF-β1、CED、DPD1、TGFB。是細(xì)胞因子轉(zhuǎn)化生長因子β超家族的多肽成員。它是一種分泌蛋白,執(zhí)行許多細(xì)胞功能,包括控制細(xì)胞生長、細(xì)胞增殖、細(xì)胞分化和凋亡。TGFB1蛋白有助于控制細(xì)胞的生長和分裂(增殖),這是細(xì)胞成熟以執(zhí)行特定功能(分化)、細(xì)胞運動(運動)和細(xì)胞自毀(凋亡)的過程。TGFB1蛋白遍布全身,在出生前的發(fā)育、血管的形成、肌肉組織和身體脂肪發(fā)育的調(diào)節(jié)、傷口愈合和免疫系統(tǒng)功能中發(fā)揮作用。TGFB1在構(gòu)成骨骼的組織中含量特別豐富,它有助于調(diào)節(jié)骨骼生長,并在細(xì)胞間空間(細(xì)胞外基質(zhì))形成的復(fù)雜晶格中含量特別高。在細(xì)胞內(nèi),這種蛋白質(zhì)被關(guān)閉(失活),直到它收到化學(xué)信號變得活躍。TGFB1在控制免疫系統(tǒng)中起著重要作用,在不同類型的細(xì)胞或不同發(fā)育階段的細(xì)胞上顯示出不同的活性。大多數(shù)免疫細(xì)胞(或白細(xì)胞)分泌TGFB1。TGFB1已被證明與TGF-β受體1、LTBP1、YWHAE、EIF3I和Decorin相互作用。
關(guān)鍵字: GMP TGF-β1;TGF-β1;TGF-β1蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。